US-based Amarillo Bio-sciences Inc (ABI) today said Indian pharmaceutical major Zydus Cadila will be marketing its dietary supplement Maxisal domestically and also in Nepal. "We are delighted that Zydus Cadila has agreed to market Maxisal and are hopeful that success in India and Nepal will lead them to expand Maxisal into some of the nearly 50 other countries in which they currently market products," ABI President and CEO Joseph Cummins said in a statement.
The US biotechnology firm has signed a supply agreement with the city-headquartered pharmaceutical group to market Maxisal in India and Nepal, a statement from ABI said. Maxisal enhances salivary function, promotes oral comfort and helps relieve dry mouth.
The US biotechnology firm has signed a supply agreement with the city-headquartered pharmaceutical group to market Maxisal in India and Nepal, a statement from ABI said. Maxisal enhances salivary function, promotes oral comfort and helps relieve dry mouth.
No comments:
Post a Comment